Panasonic Signs Joint Business Development Agreement with Startup Linkwiz to Enhance Welding Processes in Manufacturing
On June 17, 2019, Panasonic Corporation (TOKYO: 6752) announced that it has signed a joint business development agreement with Linkwiz, Inc. — a startup company specializing in the development and sales of autonomous robotic system software and technical consulting — to develop solutions to enhance welding processes in the manufacturing field. The agreement is being undertaken by Panasonic’s Connected Solutions Company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005360/en/
Yasu Higuchi, CEO of Panasonic's Connected Solutions Company (left) and Go Fukino, President of Linkwiz, Inc. (right) (Photo: Business Wire)
Under its “Gemba Process Innovation” vision, Panasonic is expanding its B2B solutions business. “The ‘gemba,’ or physical site for frontline operations, is where value is generated and problems must be confronted,” explained Yasu Higuchi, CEO of the Connected Solutions Company. “By applying our 100-years of experience and expertise gained in the manufacturing industry with our sensing technologies and edge devices, Panasonic aims to co-create with our customers and partners to solve problems at the gemba. We are advancing the Gemba Process Innovation vision with offerings to the three main areas of manufacturing, logistics and retail.”
View short video of recent Gemba Process Innovation partnership
In recent years, these industries in Japan in particular are facing pressure to improve and innovate processes as they become impacted by societal issues including a rapidly declining labor force, stagnant productivity, a drastic increase in the volume of logistics, a shift to a smarter and more automated society, and demand for work style reforms. Under such conditions, especially in the welding processes for automotive manufacturing, there is a shortage of expert workers due to difficulties in passing on technical knowledge. Moreover, with heightened environmental concern driving the expanded use of EVs, there are additional challenges to make vehicles lighter in weight and higher in strength by integrating new materials; and from a safety standpoint, to maintain a high level of quality over the long term and to strictly control manufacturing traceability.
Panasonic began its welding equipment business in 1957, and over the past 60 years has been providing welding systems and robots for the automotive, construction machinery and shipbuilding industries. On its side, Linkwiz has been developing and selling industrial-use robot control system software which utilizes proprietary algorithms. Linkwiz’s main products include software to control robots used for welding and paint application, and software for conducting automated inspection of each piece coming off a production line. Linkwiz’s products have already been adopted by a number of major enterprise customers.
Through this collaboration, Panasonic will combine its expertise in manufacturing operations cultivated over its long history with Linkwiz’s knowhow in autonomous robotic system software to optimize welding processes in the three stages of cutting, welding and inspection; and through this, make a contribution to the advancement of the manufacturing industry by addressing the pressing issues of labor shortage and quality enhancement.
Panasonic plans to further expand its partner ecosystem in order to promote its Gemba Process Innovation vision, becoming a total integrator for frontline operations in diverse fields.
Reference material: Linkwiz, Inc. Raises JPY 900M in Series B
|Company name:||Linkwiz, Inc.|
|Headquarters:||Hamamatsu city, Shizuoka pref., Japan|
|Representative:||President: Go Fukino|
|Operations:||Development and sales of autonomous robotic system software and technical consulting|
Panasonic Corporation is a worldwide leader in the development of
diverse electronics technologies and solutions for customers in the
consumer electronics, housing, automotive, and B2B businesses. The
company, which celebrated its 100th anniversary in 2018, has
expanded globally and now operates 582 subsidiaries and 87 associated
companies worldwide, recording consolidated net sales of 8.003 trillion
yen for the year ended March 31, 2019. Committed to pursuing new value
through innovation across divisional lines, the company uses its
technologies to create a better life and a better world for its
customers. To learn more about Panasonic:
Panasonic Signs Joint Business Development Agreement with Startup Linkwiz to Enhance Welding Processes in Manufacturing
[Video] Accelerating "Gemba Process Innovation" via Partnership
[Video] Expediting Innovations and Co-creation - Panasonic Executive
[Press Release] Panasonic to Open New B2B 'Customer Experience Center'
in Tokyo in January (Dec 17, 2018)
Global Communications Department
Global PR Office
Click here to go to Media Contact form
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gilead Announces Latest Data in Ongoing HIV Cure Research Program23.7.2019 20:00:00 CEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented results from two studies of investigational toll-like receptor 7 (TLR7) agonists as part of an HIV cure research program. The Phase 1 and preclinical study results demonstrate that the TLR7 agonists vesatolimod (GS-9620) and GS-986 can induce immune activation and follow earlier preclinical research suggesting that TLR7 agonists can potentially lead to viral remission, as part of combination regimens. The HIV viral reservoir is present even in virologically suppressed individuals and its elimination is regarded as a main obstacle to achieving a cure. The data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City. “While treatments have improved dramatically, people living with HIV still face a lifetime of therapy and potential complications. That reality drives our ongoing pursuit of a cure for HIV,” said Diana Brainard, MD, Senior Vice President, HIV and Emerging Viruses
Moody’s Analytics Wins Best Reporting System Provider in Waters Rankings23.7.2019 15:30:00 CEST | Press release
Moody’s Analytics, a global provider of financial intelligence, has won the award for Best Reporting System Provider in the 2019 Waters Rankings. We earned this recognition for our regulatory reporting solution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190723005679/en/ For banks and insurers, staying on top of regulatory changes is critical. Our end-to-end solution handles the entire reporting process, producing 3,000 different regulatory reports covering more than 50 jurisdictions. It automatically delivers all required updates well in advance of the relevant deadlines and makes it easy for clients to review, adjust, audit, and validate their reports. The Moody’s Analytics regulatory surveillance team boasts a wealth of experience in both local and international domains going back decades. They monitor more than 100 supervisor websites to ensure that our clients receive the updates they need in a timely fashion. “Regu
Gilead Presents New Findings on Profile of Descovy® for Potential Use as HIV Pre-exposure Prophylaxis Compared With Truvada®23.7.2019 15:00:00 CEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today presented additional results from the DISCOVER trial evaluating an investigational use of Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) for HIV pre-exposure prophylaxis (PrEP). In a sub-analysis of the DISCOVER trial, Descovy reached intracellular drug concentration levels above the estimated protective threshold significantly more quickly than Truvada (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg tablets; F/TDF), and additional pharmacokinetic data confirm that these drug concentration levels persist longer than Truvada. The results were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City. “Gilead is committed to driving advances in HIV prevention and supporting broader public health initiatives that are designed to reduce HIV infections,” said Diana Brainard, MD, Senior Vice President, HIV and Emerging Viruses, Gilead Sciences. “These
Velodyne Lidar Acquires Mapper.ai for ADAS Launch23.7.2019 15:00:00 CEST | Press release
Velodyne Lidar, Inc. today announced it has acquired mapping and localization software as well as intellectual property assets from Mapper.ai. Mapper technology will enable Velodyne to accelerate development of Vella™, breakthrough software that establishes its directional view Velarray™ lidar sensor. The Velarray is the first solid-state Velodyne lidar sensor that is embeddable and fits behind a windshield, as an integral component for superior, more effective advanced driver assistance systems (ADAS). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190723005257/en/ In addition to ADAS, Velodyne will incorporate Mapper technology into lidar-centric solutions for other emerging applications, including autonomous vehicles, last-mile delivery services, security, smart cities, smart agriculture, robotics, and unmanned aerial vehicles. (Photo: Business Wire) Mapper’s entire leadership and engineering teams will join Velodyne, bol
Wealthy Americans are increasingly willing to invest, new UBS survey finds23.7.2019 14:12:00 CEST | Press release
US high net worth individuals and business owners are expressing growing intentions to invest as US markets continue to hit record highs in 2019, according to UBS Global Wealth Management's new quarterly Investor Sentiment survey. The survey, which polled more than 3,800 wealthy investors and entrepreneurs in 17 countries, also shows US investors remain positive on the U.S. stock market but continue to rank politics and the national debt as top concerns. Fifty percent of US investors see a diversified portfolio as a hedge against US-China trade tensions specifically, in line with UBS GWM's own views, compared with 41% who favor cash. Filippo Ilardi, US Client Strategy Officer at UBS Global Wealth Management, says: "We are pleased to see a substantial increase in investors willing to put more money in the market. Wealthy Americans are concerned about the political environment and US-China trade tensions but we are encouraged that they see diversification as an important way of managing
Andersen Global Expands into Ghana23.7.2019 13:30:00 CEST | Press release
Ghana law firm, Sam Okudzeto & Associates, signed a collaboration agreement with Andersen Global, marking Andersen Global’s presence in 13 African countries and over 51 countries worldwide. Located in the capital of Accra, Sam Okudzeto & Associates is one of the largest law firms in Ghana. For the past 48 years, the firm has provided legal advice and guidance in the corporate and commercial areas, including patents and trademarks, mergers and acquisition, tax advisory, corporate banking, international trade and investment, debt recovery, mining and mineral law, industrial and labor, aviation, maritime law, petroleum oil and gas, and intellectual property. Sam Okudzeto & Associates founder and Managing Partner, Sam Okudzeto and Nene Amegatcher, have led the team since the establishment of the firm until Nene Amegatcher was elevated to the Supreme Court. The firm now has four partners and 18 lawyers who have gained international reputation for their keen knowledge and experience with Alt